Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial

Ray, KK; Nicholls, SJ; Ginsberg, HD; Johansson, JO; Kalantar-Zadeh, K; Kulikowski, E; Toth, PP; Wong, N; Cummings, JL; Sweeney, M; Schwartz, GG

Ray, KK (reprint author), Imperial Coll, Imperial Ctr Cardiovasc Dis Prevent, London, England.

AMERICAN HEART JOURNAL, 2019; 217 (): 72

Abstract

Background After an acute coronary syndrome (ACS), patients with diabetes remain at high risk for additional cardiovascular events despite use of curr......

Full Text Link